Prediction Of Outcome In Patients With Chronic Obstructive Pulmonary Disease

Abstract

The present invention relates to a method for the prognosis and/or risk assessment and/or monitoring of therapy and/or management of patients with COPD the method comprising the steps of: i) providing a sample of a bodily fluid from said patient, ii) determining in said sample the level of at least one biomarker, selected from the group consisting of pro-adrenomedullin (proADM), pronatriuretic peptide, pro-Vasopressin (proAVP) and Pro-calcitonin (PCT) or fragments thereof of at least 12 amino acids in length, iii) determining one, two or three of the BODE-index parameters body-mass index (BMI, parameter B), degree of airflow obstruction (FEV1, parameter O), dyspnea (parameter D) and exercise capacity (parameter E), iv) correlating said level of said at least one biomarker determined in step ii), in combination with said one, two or three BODE-index parameters determined in step iii) to the prognosis and/or risk assessment and/or monitoring of therapy and/or management of patients with COPD.


Claims
Download PDF
Document Preview
Document History
  • Publication: Sep 12, 2013
  • Application: Feb 26, 2013
    WO EP 2013000558 W
  • Priority: Mar 8, 2012
    EP EP 12001590 A

Download Citation


Sign in to the Lens

Feedback